Nutex Health Inc.
NUTX
$122.02
-$1.38-1.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -17.79% | 226.95% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -17.79% | 226.95% | |||
| Cost of Revenue | -20.19% | 113.29% | |||
| Gross Profit | -15.98% | 446.34% | |||
| SG&A Expenses | 68.18% | 131.88% | |||
| Depreciation & Amortization | -3.57% | 6.19% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.68% | 108.74% | |||
| Operating Income | -36.77% | 1,032.02% | |||
| Income Before Tax | -42.19% | 4,307.63% | |||
| Income Tax Expenses | 115.38% | 87.78% | |||
| Earnings from Continuing Operations | -55.76% | 1,495.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 22.69% | -2,257.77% | |||
| Net Income | -76.28% | 802.02% | |||
| EBIT | -36.77% | 1,032.02% | |||
| EBITDA | -41.76% | 945.98% | |||
| EPS Basic | -77.58% | 786.51% | |||
| Normalized Basic EPS | -69.20% | 1,073.90% | |||
| EPS Diluted | -77.00% | 745.10% | |||
| Normalized Diluted EPS | -69.11% | 1,015.45% | |||
| Average Basic Shares Outstanding | 5.79% | 2.26% | |||
| Average Diluted Shares Outstanding | 5.50% | 8.79% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||